Private company
CoCo Therapeutics
UK-based biotechnology company
CoCo Therapeutics is a United Kingdom-based biotechnology company formed in 2013 jointly by King's College London, the Wellcome Trust and Advent Venture Partners. The company will focus on development of therapeutics for Alzheimer's disease which target retinoic acid receptor alpha, specifically building on work originating in the Neuroscience Drug Discovery Unit of King's College, led by Jonathan Corcoran.2 Wikipedia text CC BY-SA 4.0
Last updated Oct 21, 2026.
Overview
- Industrypharmaceutical industry1
See how the biggest companies compare on our leaderboards
CoCo Therapeutics is a United Kingdom-based biotechnology company formed in 2013 jointly by King's College London, the Wellcome Trust and Advent Venture Partners. The company will focus on development of therapeutics for Alzheimer's disease which target retinoic acid receptor alpha, specifically building on work originating in the Neuroscience Drug Discovery Unit of King's College, led by Jonathan Corcoran.2
Timeline
- 2013Founded Founded1
Links
- WikipediaCoCo Therapeutics
- WikidataQ16949617
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataCoCo Therapeutics on Wikidata
- 2WikipediaCoCo Therapeutics on Wikipedia